Ortivus

Regulatory Filings • Jul 22, 2022

Ortivus receives an additional order from the Northern Ireland Ambulance Service

Ortivus has received a new order regarding upgraded hardware to the ambulance service in Northern Ireland. The order value is estimated to 3.2 MSEK.

The Northern Ireland Ambulance Service (NIAS) has been Ortivus' customer since 2019. Today they are using MobiMed ePR for electronic patient documentation and advanced decision support. NIAS has now decided to upgrade its hardware to an order value of 3.2 MSEK. The delivery is expected to take place at the turn of the year 2022/2023.

"We are very happy for our good collaboration with the Northern Ireland Ambulance Service. With this hardware upgrade for MobiMed ePR, they will get even better performance and functionality." - Says Reidar Gårdebäck, CEO Ortivus

Contacts

For further information, please contact

Reidar Gårdebäck, CEO

Telefon +46 8 446 45 00

About Ortivus

Ortivus develops and commercialises MobiMed, medical technology solutions for a safer and more efficient

healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' products are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm and the company has, since 1998, a wholly-owned subsidiary based in the United Kingdom.

MobiMed is a modular platform that currently is used by over 12,000 paramedics in over 2,700 emergency vechicles. The platform consists of a monitor that in real-time measures, monitors and shares patients'

vital parameters, such as, ECG, blood pressure and blood oxygenation. The system also consists of an electronic patient record for decision support, collection of patient data and clinical documentation.

MobiMed has a total weight of 3.5kg and is created to function in a demanding environment and out in

the field. The two-way communication supports telemedicine consulting with clinical experts while patient data is seamlessly integrated into the medical records at the hospitals and primary care centers. MobiMed saves time and helps healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-07-22 08:30 CEST.

Attachments

Ortivus receives an additional order from the Northern Ireland Ambulance Service